FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1844103414> ?p ?o ?g. }

• W1844103414 endingPage "504" @default.
• W1844103414 startingPage "2496" @default.
• W1844103414 abstract "The purpose of the study was to determine the capability of the midkine (MK) and cycooxygenase-2 (cox-2) gene promoter regions to function as tumor-specific promoters for use in targeted gene therapy of ovarian cancer.Established and primary ovarian cancer and mesothelial cells were transduced by adenoviral vectors containing a reporter or thymidine kinase gene expressed under the control of the MK, cox-2, or cytomegalovirus (CMV) promoters. SCID or C57BL/6 mice were injected i.p. with these same vectors. In vitro reporter gene expression and cellular cytotoxicity was determined using luciferase and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, respectively. Acute toxicity in vivo was assessed by histological evaluation of harvested tissues.Consistent activation of the MK and cox-2 promoters was noted in all of the ovarian cancer cell lines in addition to primary ovarian cancer cells. In contrast, reduced reporter activity was reported in mesothelial cells transduced with adenoviruses containing the test promoters, which was especially apparent for the cox-2 promoter. Additionally, the cox-2 promoter exhibited significantly lower reporter gene levels in liver and peritoneum than the control promoter in in vivo experiments. Tumor-cell killing induced by Adcox-2 MTK was comparable to that observed with AdCMVTK. However, a clear differential toxicity pattern was observed in favor of animals treated with Adcox-2 MTK when compared with controls.These data clearly demonstrate that the transcriptional control afforded by the cox-2 promoter is tumor-specific and is able to mitigate associated toxicity in normal tissue while maintaining therapeutic efficacy in the context of an ovarian cancer molecular chemotherapeutic approach." @default.
• W1844103414 created "2016-06-24" @default.
• W1844103414 creator A5000896222 @default.
• W1844103414 creator A5003418175 @default.
• W1844103414 creator A5006329957 @default.
• W1844103414 creator A5009193366 @default.
• W1844103414 creator A5009816072 @default.
• W1844103414 creator A5017208495 @default.
• W1844103414 creator A5022987623 @default.
• W1844103414 creator A5023997656 @default.
• W1844103414 creator A5026244234 @default.
• W1844103414 creator A5040557156 @default.
• W1844103414 creator A5041043875 @default.
• W1844103414 creator A5044095494 @default.
• W1844103414 creator A5049438419 @default.
• W1844103414 creator A5050724475 @default.
• W1844103414 creator A5051629872 @default.
• W1844103414 creator A5051668254 @default.
• W1844103414 date "2001-08-01" @default.
• W1844103414 modified "2023-10-18" @default.
• W1844103414 title "Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications." @default.
• W1844103414 cites W10427057 @default.
• W1844103414 cites W120480743 @default.
• W1844103414 cites W1484749519 @default.
• W1844103414 cites W1543782774 @default.
• W1844103414 cites W1544229812 @default.
• W1844103414 cites W1967657062 @default.
• W1844103414 cites W1968722381 @default.
• W1844103414 cites W1990723702 @default.
• W1844103414 cites W1991711054 @default.
• W1844103414 cites W2000467533 @default.
• W1844103414 cites W2009123070 @default.
• W1844103414 cites W2014228881 @default.
• W1844103414 cites W2026757769 @default.
• W1844103414 cites W2028600721 @default.
• W1844103414 cites W2042230030 @default.
• W1844103414 cites W2045527526 @default.
• W1844103414 cites W2054867592 @default.
• W1844103414 cites W2074163433 @default.
• W1844103414 cites W2076883785 @default.
• W1844103414 cites W2078296314 @default.
• W1844103414 cites W2080254729 @default.
• W1844103414 cites W2080442169 @default.
• W1844103414 cites W2089117625 @default.
• W1844103414 cites W2116150793 @default.
• W1844103414 cites W2122033091 @default.
• W1844103414 cites W2132282136 @default.
• W1844103414 cites W2170877389 @default.
• W1844103414 cites W2328244237 @default.
• W1844103414 cites W2330302356 @default.
• W1844103414 cites W2407785842 @default.
• W1844103414 cites W2438255827 @default.
• W1844103414 cites W2460302546 @default.
• W1844103414 cites W2475010670 @default.
• W1844103414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11489832" @default.
• W1844103414 hasPublicationYear "2001" @default.
• W1844103414 type Work @default.
• W1844103414 sameAs 1844103414 @default.
• W1844103414 citedByCount "20" @default.
• W1844103414 countsByYear W18441034142016 @default.
• W1844103414 crossrefType "journal-article" @default.
• W1844103414 hasAuthorship W1844103414A5000896222 @default.
• W1844103414 hasAuthorship W1844103414A5003418175 @default.
• W1844103414 hasAuthorship W1844103414A5006329957 @default.
• W1844103414 hasAuthorship W1844103414A5009193366 @default.
• W1844103414 hasAuthorship W1844103414A5009816072 @default.
• W1844103414 hasAuthorship W1844103414A5017208495 @default.
• W1844103414 hasAuthorship W1844103414A5022987623 @default.
• W1844103414 hasAuthorship W1844103414A5023997656 @default.
• W1844103414 hasAuthorship W1844103414A5026244234 @default.
• W1844103414 hasAuthorship W1844103414A5040557156 @default.
• W1844103414 hasAuthorship W1844103414A5041043875 @default.
• W1844103414 hasAuthorship W1844103414A5044095494 @default.
• W1844103414 hasAuthorship W1844103414A5049438419 @default.
• W1844103414 hasAuthorship W1844103414A5050724475 @default.
• W1844103414 hasAuthorship W1844103414A5051629872 @default.
• W1844103414 hasAuthorship W1844103414A5051668254 @default.
• W1844103414 hasConcept C101762097 @default.
• W1844103414 hasConcept C102230213 @default.
• W1844103414 hasConcept C104317684 @default.
• W1844103414 hasConcept C111599444 @default.
• W1844103414 hasConcept C121608353 @default.
• W1844103414 hasConcept C150194340 @default.
• W1844103414 hasConcept C153911025 @default.
• W1844103414 hasConcept C161733203 @default.
• W1844103414 hasConcept C207001950 @default.
• W1844103414 hasConcept C2780427987 @default.
• W1844103414 hasConcept C32470452 @default.
• W1844103414 hasConcept C40767141 @default.
• W1844103414 hasConcept C502942594 @default.
• W1844103414 hasConcept C54355233 @default.
• W1844103414 hasConcept C86803240 @default.
• W1844103414 hasConceptScore W1844103414C101762097 @default.
• W1844103414 hasConceptScore W1844103414C102230213 @default.
• W1844103414 hasConceptScore W1844103414C104317684 @default.
• W1844103414 hasConceptScore W1844103414C111599444 @default.
• W1844103414 hasConceptScore W1844103414C121608353 @default.
• W1844103414 hasConceptScore W1844103414C150194340 @default.

• next